Prevalence of anemia among Quebec Cree infants from 2002 to 2007 compared with 1995 to 2000

Noreen Willows1, David Dannenbaum, Sophie Vadeboncoeur

  • 1Alberta Institute for Human Nutrition, University of Alberta, Edmonton, Canada. noreen.willows@ualberta.ca

Insights

Anemia screening in Cree infants in Quebec showed a significant decrease in prevalence from 31.7% to 12.5% between 1995-2000 and 2002-2007. This suggests a potential shift from universal to targeted screening for anemia in infants.

Area of Science:

  • Pediatric Health
  • Public Health Interventions
  • Nutritional Anemia

Background:

  • Anemia screening at 9 months is crucial for infant health.
  • Previous data indicated a high prevalence of anemia in Quebec Cree infants.
  • Evaluating screening effectiveness is essential for resource allocation.

Purpose of the Study:

  • To assess the change in anemia prevalence among Cree infants in Quebec.
  • To compare anemia rates between 1995-2000 and 2002-2007 screening periods.
  • To inform decisions regarding the continuation of universal infant anemia screening.

Main Methods:

  • Cross-sectional study comparing two distinct screening periods (1995-2000 and 2002-2007).
  • Analysis of anemia prevalence based on hemoglobin concentration in 716 infants (1995-2000) and 1325 infants (2002-2007).
  • Used non-overlapping 95% confidence intervals (CIs) to determine statistical significance.

Main Results:

  • Anemia prevalence (hemoglobin < 110 g/L) decreased significantly from 31.7% to 12.5%.
  • Iron deficiency anemia prevalence (hemoglobin < 100 g/L) dropped from 7.5% to 2.0%.
  • Mean hemoglobin levels increased from 114 g/L to 121 g/L.

Conclusions:

  • The reduced anemia prevalence suggests screening interventions have been effective.
  • While lower, the 12.5% anemia rate is higher than non-Aboriginal infants (8.0%).
  • Consideration of targeted screening for high-risk infants is recommended, pending further risk factor studies.
Abstract

Related Concept Videos

Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...